Upstate company wins award for heart attack prevention technology
You probably already know that cardiovascular disease is the leading cause of death in the world. Our next guest’s company is targeting that problem with a new drug delivery platform that won them the most recent Innovision Technology Development Award. Mike Switzer interviews Matthias Bruegelmans, CEO of Elastrin Therapeutics in Greenville, SC.
Mike Switzer Matthias Bruegelmans Innovision Technology Development Award Innovision Technology Development Elastrin Therapeutics
Source: southcarolinapublicradio.org